Create account

Coverage dated September 25, 2022 to September 26, 2022

Pfizer asks FDA to approve omicron COVID-19 booster shots for 5- to 11-year-olds

Headline from Foxla

Elementary-aged children already received smaller doses of Pfizer’s original COVID-19 vaccine, a third of the dose given to everyone 12 and older.

Foxla's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

46 articles, oldest first.

  1. NBC Chicago

    Pfizer Asks FDA to Authorize Omicron Covid Booster Shots for Kids Ages 5 to 11 (opens NBC Chicago)

    Published

    NBC Chicago's feed description

    Pfizer’s application to the FDA comes before clinical trial results of the omicron BA.5 booster shots have been published.

  2. Courthouse News Service

    Pfizer seeks to expand omicron booster to 5- to 11-year-olds (opens Courthouse News Service)

    Published

    Courthouse News Service's feed description

    Pfizer and its partner BioNTech also announced a new study of the omicron-focused booster in even younger children, those ages 6 months through 4 years, to test different doses.

  3. NBC10 Philadelphia

    Pfizer Seeks to Expand Omicron Booster Authorization For Kids 5- to 11-Year-Olds (opens NBC10 Philadelphia)

    Published

    NBC10 Philadelphia's feed description

    Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11.

  4. Just the News

    Pfizer asks FDA for authorization of new booster for children, ages 5-11 (opens Just the News)

    Published

    Just the News's feed description

    The booster is already available to those who are 12 years old and up.

  5. FOX 5 New York

    Bivalent booster: Pfizer seeks to expand shot to 5- to 11-year-olds (opens FOX 5 New York)

    Published

    FOX 5 New York's feed description

    Pfizer is asking the FDA to expand use of its updated COVID-19 vaccine booster shot to children ages 5 to 11. The so-called bivalent shot is meant to be more effective against omicron variants of the coronavirus.

  6. France 24

    Pfizer files for US approval for Omicron booster for kids (opens France 24)

    Published

    France 24's feed description

    Pfizer and BioNTech have asked United States health officials to authorize their Omicron-targeting Covid booster vaccine for children aged 5 to 11, the companies said Monday.

  7. Bloomberg

    Pfizer Asks FDA to Clear Omicron-Targeted Shot for Children (opens Bloomberg)

    Published

    Bloomberg's feed description

    Pfizer Inc. and BioNTech SE asked US regulators to clear their booster shot that targets fast-spreading variants of omicron for children ages 5 to 11, which would bring the latest preventive technology to a younger population.

  8. PBS NewsHour

    Pfizer asks FDA for approval to expand omicron booster to 5- to 11-year-olds (opens PBS NewsHour)

    Published

    PBS NewsHour's feed description

    Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11.

  9. Foxla

    Pfizer asks FDA to approve omicron COVID-19 booster shots for 5- to 11-year-olds (opens Foxla)

    Published

    Foxla's feed description

    Elementary-aged children already received smaller doses of Pfizer’s original COVID-19 vaccine, a third of the dose given to everyone 12 and older.

  10. Politico

    Pfizer, Moderna seek Omicron booster EUAs for kids (opens Politico)

    Published

    Politico's feed description

    Moderna said on Friday that it had asked the FDA to authorize its bivalent Covid-19 booster shot for 12- to 17-year-olds and 6- to 11-year-olds.

  11. Delaware Public Media

    Pfzier and Moderna seek authorization of omicron booster for kids ages 5-11 (opens Delaware Public Media)

    Published

    Delaware Public Media's feed description

    Pfzier-BioNTech and Moderna are asking the Food and Drug Administration to authorize the new omicron boosters for young children.

  12. FOX Business

    Pfizer seeks approval for omicron booster in kids over 5 years old (opens FOX Business)

    Published

    FOX Business's feed description

    Pfizer is seeking approval from the FDA for its updated COVID-19 booster shot targeting the omicron variant in kids between the ages of 5 and 11.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

Pfizer asks FDA to approve omicron COVID-19 booster shots for 5- to 11-year-olds | Since Then